Accessibility Menu
 
Alkermes Plc logo

Alkermes Plc

(NASDAQ) ALKS

Current Price$29.95
Market Cap$4.89B
Since IPO (1991)+443%
5 Year+53%
1 Year-13%
1 Month-9%

Alkermes Plc Financials at a Glance

Market Cap

$4.89B

Revenue (TTM)

$1.48B

Net Income (TTM)

$241.66M

EPS (TTM)

$1.43

P/E Ratio

20.50

Dividend

$0.00

Beta (Volatility)

0.59 (Low)

Price

$29.95

Volume

3,419,133.21

Open

$29.16

Previous Close

$29.92

Daily Range

$29.07 - $30.17

52-Week Range

$25.16 - $36.32

ALKS: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Alkermes Plc

Industry

Biotechnology

Employees

2,050

CEO

Richard F. Pops

Headquarters

Dublin, 4, IE

ALKS Financials

Key Financial Metrics (TTM)

Gross Margin

86%

Operating Margin

17%

Net Income Margin

16%

Return on Equity

15%

Return on Capital

13%

Return on Assets

10%

Earnings Yield

4.88%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.89B

Shares Outstanding

166.65M

Volume

3.42M

Short Interest

0.00%

Avg. Volume

2.07M

Financials (TTM)

Gross Profit

$1.27B

Operating Income

$253.96M

EBITDA

$330.89M

Operating Cash Flow

$520.75M

Capital Expenditure

$40.42M

Free Cash Flow

$480.33M

Cash & ST Invst.

$1.32B

Total Debt

$70.00M

Alkermes Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$384.55M

-10.6%

Gross Profit

$332.74M

-9.6%

Gross Margin

86.53%

N/A

Market Cap

$4.89B

N/A

Market Cap/Employee

$2.72M

N/A

Employees

1,800

N/A

Net Income

$49.34M

-66.3%

EBITDA

$76.50M

-57.8%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$1.25B

+84.8%

Accounts Receivable

$334.02M

-14.2%

Inventory

$196.63M

+7.5%

Long Term Debt

$63.25M

-8.8%

Short Term Debt

$6.75M

+9.4%

Return on Assets

9.55%

N/A

Return on Invested Capital

12.78%

N/A

Free Cash Flow

$170.09M

-5.8%

Operating Cash Flow

$170.07M

-10.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
TGTXTG Therapeutics, Inc.
$31.98+0.50%
CRSPCRISPR Therapeutics AG
$47.55+0.98%
AKROAkero Therapeutics, Inc.
$54.65+0.00%
PTCTPTC Therapeutics, Inc.
$67.00+0.37%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$41.23-0.07%
EEIQEpicQuest Education Group International
$8.44+2.09%
MARAMara Holdings
$8.58+0.04%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.92+0.08%

Questions About ALKS

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.